137 related articles for article (PubMed ID: 29665941)
1. [Research on Ralation of Long Non-coding RNA with Diffuse Large B-cell Lymphomas -Review].
Wu YY; Xing YR; Yu DN
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Apr; 26(2):609-614. PubMed ID: 29665941
[TBL] [Abstract][Full Text] [Related]
2. Discovery and validation of immune-associated long non-coding RNA biomarkers associated with clinically molecular subtype and prognosis in diffuse large B cell lymphoma.
Zhou M; Zhao H; Xu W; Bao S; Cheng L; Sun J
Mol Cancer; 2017 Jan; 16(1):16. PubMed ID: 28103885
[TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA HULC predicts poor clinical outcome and represents pro-oncogenic activity in diffuse large B-cell lymphoma.
Peng W; Wu J; Feng J
Biomed Pharmacother; 2016 Apr; 79():188-93. PubMed ID: 27044827
[TBL] [Abstract][Full Text] [Related]
4. Transcriptome sequencing reveals thousands of novel long non-coding RNAs in B cell lymphoma.
Verma A; Jiang Y; Du W; Fairchild L; Melnick A; Elemento O
Genome Med; 2015 Nov; 7():110. PubMed ID: 26521025
[TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA LUNAR1 associates with cell proliferation and predicts a poor prognosis in diffuse large B-cell lymphoma.
Peng W; Feng J
Biomed Pharmacother; 2016 Feb; 77():65-71. PubMed ID: 26796267
[TBL] [Abstract][Full Text] [Related]
6. Predictive analysis of long non-coding RNA expression profiles in diffuse large B-cell lymphoma.
Zhu D; Fang C; Li X; Geng Y; Li R; Wu C; Jiang J; Wu C
Oncotarget; 2017 Apr; 8(14):23228-23236. PubMed ID: 28423571
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of long noncoding RNA PEG10 associates with poor prognosis in diffuse large B cell lymphoma with facilitating tumorigenicity.
Peng W; Fan H; Wu G; Wu J; Feng J
Clin Exp Med; 2016 May; 16(2):177-82. PubMed ID: 25864113
[TBL] [Abstract][Full Text] [Related]
8. LincRNA-p21 predicts favorable clinical outcome and impairs tumorigenesis in diffuse large B cell lymphoma patients treated with R-CHOP chemotherapy.
Peng W; Wu J; Feng J
Clin Exp Med; 2017 Feb; 17(1):1-8. PubMed ID: 26475621
[TBL] [Abstract][Full Text] [Related]
9. Elevated RNA expression of long non‑coding HOTAIR promotes cell proliferation and predicts a poor prognosis in patients with diffuse large B cell lymphoma.
Yan Y; Han J; Li Z; Yang H; Sui Y; Wang M
Mol Med Rep; 2016 Jun; 13(6):5125-31. PubMed ID: 27122348
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA as a novel biomarker and therapeutic target in aggressive B-cell non-Hodgkin lymphoma: A systematic review.
Khanmohammadi S; Fallahtafti P
J Cell Mol Med; 2023 Jul; 27(14):1928-1946. PubMed ID: 37246627
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNAs expression levels in diffuse large B-cell lymphoma: An in silico analysis.
Dousti F; Shahrisa A; Ansari H; Hajjari M; Tahmasebi Birgani Y; Mohammadiasl J; Tahmasebi Birgani M
Pathol Res Pract; 2018 Sep; 214(9):1462-1466. PubMed ID: 30104077
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic strategy with artificially-designed i-lncRNA targeting multiple oncogenic microRNAs exhibits effective antitumor activity in diffuse large B-cell lymphoma.
Su Y; Sun B; Lin X; Zhao X; Ji W; He M; Qian H; Song X; Yang J; Wang J; Chen J
Oncotarget; 2016 Aug; 7(31):49143-49155. PubMed ID: 27172795
[TBL] [Abstract][Full Text] [Related]
13. Discovery and validation of the tumor-suppressive function of long noncoding RNA PANDA in human diffuse large B-cell lymphoma through the inactivation of MAPK/ERK signaling pathway.
Wang Y; Zhang M; Xu H; Wang Y; Li Z; Chang Y; Wang X; Fu X; Zhou Z; Yang S; Wang B; Shang Y
Oncotarget; 2017 Sep; 8(42):72182-72196. PubMed ID: 29069778
[TBL] [Abstract][Full Text] [Related]
14. Microarray expression profiles of long non-coding RNAs in germinal center-like diffuse large B-cell lymphoma.
Gao HY; Wu B; Yan W; Gong ZM; Sun Q; Wang HH; Yang W
Oncol Rep; 2017 Sep; 38(3):1363-1372. PubMed ID: 28713985
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNAs: Novel insights into hepatocelluar carcinoma.
He Y; Meng XM; Huang C; Wu BM; Zhang L; Lv XW; Li J
Cancer Lett; 2014 Mar; 344(1):20-27. PubMed ID: 24183851
[TBL] [Abstract][Full Text] [Related]
16. A potential panel of six-long non-coding RNA signature to improve survival prediction of diffuse large-B-cell lymphoma.
Sun J; Cheng L; Shi H; Zhang Z; Zhao H; Wang Z; Zhou M
Sci Rep; 2016 Jun; 6():27842. PubMed ID: 27292966
[TBL] [Abstract][Full Text] [Related]
17. Targeting long non-coding RNAs in cancers: progress and prospects.
Li CH; Chen Y
Int J Biochem Cell Biol; 2013 Aug; 45(8):1895-910. PubMed ID: 23748105
[TBL] [Abstract][Full Text] [Related]
18. Novel drug targets for personalized precision medicine in relapsed/refractory diffuse large B-cell lymphoma: a comprehensive review.
Camicia R; Winkler HC; Hassa PO
Mol Cancer; 2015 Dec; 14():207. PubMed ID: 26654227
[TBL] [Abstract][Full Text] [Related]
19. Systematic Analysis of Competing Endogenous RNA Networks in Diffuse Large B-Cell Lymphoma and Hodgkin's Lymphoma.
Kang J; Yao P; Tang Q; Wang Y; Zhou Y; Huang J
Front Genet; 2020; 11():586688. PubMed ID: 33193722
[TBL] [Abstract][Full Text] [Related]
20. [Role of miR-155 in pathogenesis of diffuse large B cell lymphoma and its possible mechanism].
Shi JS; Zhang J; Li J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Jun; 22(3):869-72. PubMed ID: 24989312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
